0VQ.F PURETECH HEALTH PLC LS 1

Healthcare Oil, Gas & Consumable Fuels Frankfurt Exchange
- EUR
Market cap
-
P/E
-
P/B
-
ROE
-
Dividend yield
-
Fundamental score
-

Is 0VQ.F undervalued?

Graham number

The Graham number of PURETECH HEALTH PLC LS 1 cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

PURETECH HEALTH PLC LS 1 fundamental analysis

No fundamental analysis for PURETECH HEALTH PLC LS 1 yet.

PURETECH HEALTH PLC LS 1 stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About PURETECH HEALTH PLC LS 1

PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. It is developing LYT-100, a Phase 3-ready therapeutic candidate with the potential to establish a new standard of care (SOC) for the treatment of idiopathic pulmonary fibrosis (IPF) and other fibrotic lung diseases and LYT-200, a fully human IgG4 monoclonal antibody. The company also develops SPT-300, a Glyphed oral prodrug of allopregnano…

Full company profile